Sarah Lueck, senior policy analyst from the Center on Budget and Policy Priorities, recommends increased transparency of healthcare consolidation, and more research on its impacts, particularly regarding benefits for consumers.
Sarah Lueck, senior policy analyst from the Center on Budget and Policy Priorities, recommends increased transparency of healthcare consolidation, and more research on its impacts, particularly regarding benefits for consumers.
Transcript (modified)
How can healthcare consolidation be done right to ensure it is lowering costs while improving quality?
When we’re thinking about the health insurance mergers that were recently announced, we need to think about whether consolidation is good for consumers at all. I think that’s the first question. Clearly, there are a lot of issues raised about consolidation that could be potential concerns for consumers, from higher premiums for their insurance to narrower networks or increased cost-sharing, and then our less competitive marketplace, now and in the future, could be really problematic for consumers.
So I think it’s worth taking a closer look at the impact on consumers and deciding whether it’s even a good idea. Looking forward I think doing more research and having more transparency in terms of the data that’s available on the impact of any consolidation that happens within the healthcare industry would be really helpful.
So to the extent that a plan or a hospital or other providers are saying that a merger or an acquisition is going to help improve things for consumers, we need to see whether that’s true, and the way you can structure those types of arrangements to make sure that the benefits accrue the consumer.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More